United Pharm (033270) — Strategic Asset Allocation Index
United Pharm (033270) has a Strategic Asset Allocation Index of 50.4% as of September 2015. Strategic assets (PP&E of ₩74.12 Billion plus long-term investments of ₩11.90 Billion) total ₩86.02 Billion, measured against net assets of ₩170.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 033270 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
United Pharm Strategic Asset Allocation Index (2011–2014)
This chart shows how United Pharm's Strategic Asset Allocation Index has evolved across 4 annual periods from 2011 to 2014. As of September 2015, the index stands at 50.4%, representing strategic assets of ₩86.02 Billion against net assets of ₩170.68 Billion KRW. See United Pharm (033270) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for United Pharm (2011–2014)
The table below presents the year-by-year Strategic Asset Allocation Index for United Pharm from 2011 to 2014, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see United Pharm stock valuation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2014 | 48.9% | ₩79.07 Billion | ₩67.00 Billion | ₩12.07 Billion | ₩161.83 Billion | ▼ -3.6 pp |
| 2013 | 52.5% | ₩74.20 Billion | ₩65.49 Billion | ₩8.71 Billion | ₩141.44 Billion | ▲ +1.4 pp |
| 2012 | 51.0% | ₩68.12 Billion | ₩59.69 Billion | ₩8.43 Billion | ₩133.48 Billion | ▼ -3.9 pp |
| 2011 | 55.0% | ₩62.14 Billion | ₩53.65 Billion | ₩8.49 Billion | ₩113.04 Billion | — |